Immunogenicity and reactogenicity of Infanrixâ¢ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrixâ¢ and Pediarixâ¢

Article ID	Journal	Published Year	Pages	File Type
10963426	Vaccine	2015	9 Pages	PDF

Abstract

Routine booster DTaP was immunogenic with an acceptable safety profile when co-administered with MenACWY-TT vaccine in HibMenCY-TT-primed toddlers. These data support the administration of a fourth DTaP dose following a 4-dose HibMenCY-TT vaccination series, or co-administered with MenACWY-TT in HibMenCY-TT-primed children.

Keywords

Polyribosylribitol phosphate PrP COAD IMD PRN DTaP vaccine Haemophilus influenzae type b conjugate vaccine GMC DTaP MenACWY-TT FHA SAE 95 percent confidence interval 95% CI ATP United States according-to-protocol Invasive meningococcal disease ACIP tetanus toxoid pertussis toxin adverse event Serious adverse event Filamentous hemagglutinin Co-administration Quadrivalent meningococcal vaccine Pertactin Advisory Committee on Immunization Practices

Related Topics

Life Sciences Immunology and Microbiology Immunology

Preview

Immunogenicity and reactogenicity of Infanrixâ¢ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrixâ¢ and Pediarixâ¢

Authors

Michael Leonardi, Thomas Latiolais, Kwabena Sarpong, Michael Simon, Jerry Twiggs, Paul Lei, Stephen Rinderknecht, Mark Blatter, Veronique Bianco, Yaela Baine, Leonard R. Friedland, Carmen Baccarini, Jacqueline M. Miller,